Business · 04/08/1995Updated: 10/18/2026 · 1 min read
FDA Withdraws Approval of 16 Animal Drug Applications
Summary
The Food and Drug Administration (FDA) is removing the approvals of 16 new animal drug applications (NADA's) for products including Piperazine Adipate Powder, Diprenorphine Hydrochloride Injection, and Certain Nitrofuran and Buquinolate Products, held by Proctor & Gamble Pharmaceuticals, Inc., Happy Jack, Inc., and Lemmon Co.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →